Drug-Induced Liver Toxicity Authors 2007

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research

AASLD-FDA-NIH-PhRMA*- Hepatotoxicity Special Interest Group Meeting

Speaker Lists

2008 Speaker List

Name	e-mail	Institution
Mark Avigan	mark.avigan@fda.hhs.gov	FDA/CDER
Jay Barth	Jay_Barth@merck.com	Merck
Andrew Bartholomaeus	Andrew.bartholomaeus@health.gov.au	TGA Aus
Jack Bloom	bloom_john_c@lilly.com	Lilly
Naga Chalasani	nchalasa@iupui.edu	Indiana University
Kate Gelperin	kate.gelperin@fda.hhs.gov	FDA/CDER
Sara Goldkind	sara.goldkind@fda.hhs.gov	FDA/OC
Alan Goldhammer	Agoldhammer@phrma.org	PhRMA
Ted Guo	ted.guo@fda.hhs.gov	FDA/CDER
Arthur Holden	aholden@earthlink.net	SAEC
Christine Hunt	cmh28616@gsk.com	GSK
William Lee	william.lee@utsouthwestern.edu	UT SW
Julie Papay	julie.i.papay@gsk.com	GSK
John Pears	John.Pears@astrazeneca.com	AstraZeneca
Arie Regev	regev_arie@lilly.com	Lilly
Adrian Reuben	reubena@musc.edu	Medical U of SC
Don Rockey	don.rockey@utsouthwestern.edu	UT SW
Leonard Seeff	ls198y@nih.gov	NIH
Paul Seligman	paul.seligman@fda.hhs.gov	NIH/CDER
John Senior	john.senior@fda.hhs.gov	FDA/CDER
Robert Temple	robert.temple@fda.hhs.gov	FDA/CDER
Robert Tipping	robert_tipping@merck.com	Merck
Jack Uetrecht	jack.uetrecht@utoronto.ca	U Toronto
John Vierling	Vierling@bcm.tmc.edu	Baylor U
Paul Watkins	pbwatkins@med.unc.edu	U NC
Janet Woodcock	janet.woodcock@fda.hhs.gov	FDA/OC

2007 Speaker List

Speaker	Session	E-mail
Andersson	1	Tommy.B.Andersson@astrazeneca.com
Avigan	2	Mark.Avigan@fda.hhs.gov
Bonkovsky	3	bonkovsky@uchc.edu
Fontana	2	rfontana@med.umich.edu
He	1	ruyi.he@fda.hhs.gov
Kirby	1	deborah.s.kirby@pfizer.com
Kaplowitz	1,2,3	kaplowit@hsc.usc.edu
Lee	2	William.Lee@utsouthwestern.edu
Lesko	1	lawrence.lesko@fda.hhs.gov
Lewis	2	lewisjh@gunet.georgetown.edu
Mehendale	2	mehendale@ulm.edu
Seeff	3	ls198y@nih.gov
Senior	0,1	john.senior@fda.hhs.gov
Stern	1	jstern@rdg.boehringer-ingelheim.com
Taub	2	Rebecca.Taub@roche.com
Temple	2	robert.temple@fda.hhs.gov
Uetrecht	3	Jack.Uetrecht@utoronto.ca
Watkins	1	pbwatkins@med.unc.edu
Vierling	3	vierling@bcm.tmc.edu
Woodcock	1	janet.woodcock@fda.hhs.gov

2006 Speaker List

Speaker	Session	E-mail
Avigan	3	Mark.Avigan@fda.hhs.gov
Bonkovsky	3	bonkovsky@uchc.edu
Burns	2	Dan.Burns@gsk.com
Chalasani	3	nchalasa@iupui.edu
Davern	3	tdavern@itsa.ucsf.edu
Dragan	1	Yvonne.Dragan@astrazenecalcom
Freston	3	freston@nso.ucuc.edu
Lee	2	William.Lee@utsouthwestern.edu
McBurney	1	RMcBurney@bg-medicine.com
Mehendale	2	mehendale@ulm.edu
Pohl	2	lp16o@nih.gov
Robertson	1	Donald.Robertson@pfizer.com
Rockey	3	Don.Rockey@utsouthwestern.edu
Sanders	1	jsanders@prdus.jnj.com
Seeff	3	ls198y@nih.gov
Senior	2	john.senior@fda.hhs.gov
Taub	2	Rebecca.Taub@roche.com
Thomas	1	cthomas@lilly.com
Uetrecht	3	Jack.Uetrecht@utoronto.ca
Watkins	1	pbwatkins@med.unc.edu

2005 Speaker List

Speaker	Session	E-mail
Avigan	1	Mark.Avigan@fda.hhs.gov
Fontana	1	rfontana@med.umich.edu
Goodsaid	2	Federico.Goodsaid@fda.hhs.gov
Lee	1	William.Lee@utsouthwestern.edu
Meador	2	vmeador@amgen.com
Mendrick	2	dmendrick@genelogic.com
Navarro	2	victor.navarro@jefferson.edu
Read	2	Holly.Read@abbott.com
Roses	1	allen.d.roses@gsk.com
Sanders	1	jsanders@prdus.jnj.com
Senior	1	john.senior@fda.hhs.gov
Serrano	2	js362q@nih.gov
Watkins	1	pbwatkins@med.unc.edu

For earlier presentations 2001-2004, please contact John.Senior@fda.hhs.gov or Lana.Pauls@fda.hhs.gov for how to reach those speakers.

PDF requires the free Adobe Acrobat Reader

Date created: March 9, 2007